| 1 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
TNFAIP3 |
| 2 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
TNFAIP3 |
| 3 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
TNFAIP3 |
| 4 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
TNFAIP3 |
| 5 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
TNFAIP3 |
| 6 |
34952945 |
10.1038/s41379-021-01002-6 |
2022 |
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. |
TNFAIP3 |
| 7 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
TNFAIP3 |
| 8 |
35075971 |
10.1080/10428194.2021.2010060 |
2022 |
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. |
TNFAIP3 |
| 9 |
35089437 |
10.1007/s00018-022-04139-y |
2022 |
A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. |
TNFAIP3 |
| 10 |
35236331 |
10.1186/s12885-022-09237-5 |
2022 |
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma. |
TNFAIP3 |
| 11 |
35937947 |
10.1155/2022/6441139 |
2022 |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. |
TNFAIP3 |
| 12 |
36001451 |
10.1097/PAS.0000000000001956 |
2022 |
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. |
TNFAIP3 |
| 13 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
TNFAIP3 |
| 14 |
32785655 |
10.1182/blood.2019004713 |
2021 |
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL. |
TNFAIP3 |
| 15 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
TNFAIP3 |
| 16 |
33263441 |
10.1080/17474086.2021.1856652 |
2021 |
Development of molecular intervention strategies for B-cell lymphoma. |
TNFAIP3 |
| 17 |
33311649 |
10.1038/s41379-020-00720-7 |
2021 |
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. |
TNFAIP3 |
| 18 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
TNFAIP3 |
| 19 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
TNFAIP3 |
| 20 |
34203889 |
10.3390/cancers13122993 |
2021 |
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. |
TNFAIP3 |
| 21 |
34312841 |
10.1111/bjh.17719 |
2021 |
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. |
TNFAIP3 |
| 22 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
TNFAIP3 |
| 23 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
TNFAIP3 |
| 24 |
34558064 |
10.1111/bjh.17824 |
2021 |
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. |
TNFAIP3 |
| 25 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
TNFAIP3 |
| 26 |
35528192 |
10.1158/2767-9764.crc-21-0022 |
2021 |
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. |
TNFAIP3 |
| 27 |
31807922 |
10.1007/s00428-019-02691-w |
2020 |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. |
TNFAIP3 |
| 28 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
TNFAIP3 |
| 29 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
TNFAIP3 |
| 30 |
32316399 |
10.3390/cancers12040986 |
2020 |
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. |
TNFAIP3 |
| 31 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
TNFAIP3 |
| 32 |
32738175 |
10.1002/hon.2784 |
2020 |
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis. |
TNFAIP3 |
| 33 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
TNFAIP3 |
| 34 |
33139544 |
10.1073/pnas.2014470117 |
2020 |
Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma. |
TNFAIP3 |
| 35 |
33154951 |
10.3389/fonc.2020.591577 |
2020 |
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. |
TNFAIP3 |
| 36 |
30211726 |
10.1097/PAS.0000000000001154 |
2019 |
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. |
TNFAIP3 |
| 37 |
31320741 |
10.1038/s41598-019-46906-1 |
2019 |
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. |
TNFAIP3 |
| 38 |
31378966 |
10.1002/ajh.25600 |
2019 |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. |
TNFAIP3 |
| 39 |
31403034 |
10.3389/fonc.2019.00683 |
2019 |
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. |
TNFAIP3 |
| 40 |
31444033 |
10.1016/j.jaut.2019.102317 |
2019 |
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. |
TNFAIP3 |
| 41 |
31816062 |
10.1182/bloodadvances.2019001012 |
2019 |
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. |
TNFAIP3 |
| 42 |
29695787 |
10.1038/s41556-018-0084-5 |
2018 |
Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2. |
TNFAIP3 |
| 43 |
29765142 |
10.1038/s41379-018-0064-0 |
2018 |
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. |
TNFAIP3 |
| 44 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
TNFAIP3 |
| 45 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
TNFAIP3 |
| 46 |
27297871 |
10.1111/his.13015 |
2017 |
Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. |
TNFAIP3 |
| 47 |
28073005 |
10.1016/j.ccell.2016.12.003 |
2017 |
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT. |
TNFAIP3 |
| 48 |
28152507 |
10.18632/oncotarget.14928 |
2017 |
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. |
TNFAIP3 |
| 49 |
28153771 |
10.1016/j.ebiom.2017.01.027 |
2017 |
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study. |
TNFAIP3 |
| 50 |
28288707 |
10.1016/j.beha.2016.09.002 |
2017 |
MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism. |
TNFAIP3 |
| 51 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
TNFAIP3 |
| 52 |
28682481 |
10.1002/path.4933 |
2017 |
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. |
TNFAIP3 |
| 53 |
28892161 |
10.1002/path.4982 |
2017 |
A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. |
TNFAIP3 |
| 54 |
26437781 |
10.1038/leu.2015.267 |
2016 |
A20 targets caspase-8 and FADD to protect HTLV-I-infected cells. |
TNFAIP3 |
| 55 |
26752547 |
10.1097/PAS.0000000000000592 |
2016 |
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma. |
TNFAIP3 |
| 56 |
26819451 |
10.1158/1078-0432.CCR-15-2305 |
2016 |
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. |
TNFAIP3 |
| 57 |
27248180 |
10.18632/oncotarget.9678 |
2016 |
The genetic landscape of dural marginal zone lymphomas. |
TNFAIP3 |
| 58 |
27452667 |
10.1016/j.semcancer.2016.07.003 |
2016 |
MALT lymphoma: A paradigm of NF-κB dysregulation. |
TNFAIP3 |
| 59 |
27566587 |
10.18632/oncotarget.11548 |
2016 |
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. |
TNFAIP3 |
| 60 |
25428260 |
10.1038/leu.2014.330 |
2015 |
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. |
TNFAIP3 |
| 61 |
25779943 |
10.1158/1078-0432.CCR-14-2759 |
2015 |
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. |
TNFAIP3 |
| 62 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
TNFAIP3 |
| 63 |
26366710 |
10.1038/nm.3943 |
2015 |
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. |
TNFAIP3 |
| 64 |
26599546 |
10.1371/journal.pone.0139663 |
2015 |
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. |
TNFAIP3 |
| 65 |
24362818 |
10.1038/ng.2856 |
2014 |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. |
TNFAIP3 |
| 66 |
24491438 |
10.1158/2159-8290.CD-13-0915 |
2014 |
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. |
TNFAIP3 |
| 67 |
24870942 |
10.1007/s00277-014-2116-y |
2014 |
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. |
TNFAIP3 |
| 68 |
25364581 |
10.7497/j.issn.2095-3941.2014.03.006 |
2014 |
The gene expression patterns of BMPR2, EP300, TGFβ2, and TNFAIP3 in B-Lymphoma cells. |
TNFAIP3 |
| 69 |
25384343 |
10.1186/s40001-014-0062-8 |
2014 |
Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia. |
TNFAIP3 |
| 70 |
23292937 |
10.1073/pnas.1205299110 |
2013 |
Genetic heterogeneity of diffuse large B-cell lymphoma. |
TNFAIP3 |
| 71 |
23677497 |
10.1007/s13105-013-0259-2 |
2013 |
Bcl10 is an essential regulator for A20 gene expression. |
TNFAIP3 |
| 72 |
23720088 |
10.1002/ajh.23490 |
2013 |
Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. |
TNFAIP3 |
| 73 |
24349473 |
10.1371/journal.pone.0083244 |
2013 |
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. |
TNFAIP3 |
| 74 |
22102703 |
10.3324/haematol.2011.054080 |
2012 |
BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. |
TNFAIP3 |
| 75 |
22382892 |
10.1038/leu.2012.28 |
2012 |
Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment. |
TNFAIP3 |
| 76 |
22397314 |
10.3109/10428194.2012.668286 |
2012 |
Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma. |
TNFAIP3 |
| 77 |
22808296 |
NA |
2012 |
Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma. |
TNFAIP3 |
| 78 |
21266526 |
10.1158/1078-0432.CCR-10-1859 |
2011 |
A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. |
TNFAIP3 |
| 79 |
21324920 |
10.1158/0008-5472.CAN-10-2525 |
2011 |
Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas. |
TNFAIP3 |
| 80 |
21745165 |
10.3109/10428194.2011.596968 |
2011 |
Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases. |
TNFAIP3 |
| 81 |
20544211 |
10.1007/s00401-010-0709-7 |
2010 |
Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma. |
TNFAIP3 |
| 82 |
19412164 |
10.1038/nature07968 |
2009 |
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. |
TNFAIP3 |
| 83 |
18223652 |
10.1038/ni1561 |
2008 |
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. |
TNFAIP3 |
Datasets
Models
